Yanhong Pan
Fujian Medical University(CN)Nanjing University of Chinese Medicine(CN)First Affiliated Hospital of Fujian Medical University(CN)Henan Institute of Science and Technology(CN)
Publications by Year
Research Areas
Cancer, Hypoxia, and Metabolism, Cancer Cells and Metastasis, Phytochemicals and Antioxidant Activities, Postharvest Quality and Shelf Life Management, Inflammasome and immune disorders
Most-Cited Works
- → The STING antagonist H‐151 ameliorates psoriasis via suppression of STING/NF‐κB‐mediated inflammation(2021)98 cited
- → Beta‐elemene inhibits breast cancer metastasis through blocking pyruvate kinase M2 dimerization and nuclear translocation(2019)72 cited
- → Cryptotanshinone activates AMPK-TSC2 axis leading to inhibition of mTORC1 signaling in cancer cells(2017)50 cited
- → Breaking Glucose Transporter 1/Pyruvate Kinase M2 Glycolytic Loop Is Required for Cantharidin Inhibition of Metastasis in Highly Metastatic Breast Cancer(2019)43 cited
- → Cryptotanshinone inhibition of mammalian target of rapamycin pathway is dependent on oestrogen receptor alpha in breast cancer(2017)42 cited
- → A narrative review of circulating tumor cells clusters: A key morphology of cancer cells in circulation promote hematogenous metastasis(2022)42 cited